Marta Montero
Overview
Explore the profile of Marta Montero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aliu J, Montero M, Dorman J
Cureus
. 2025 Jan;
16(12):e76178.
PMID: 39840173
Cardiac tamponade is widely known to be associated with life-threatening hypotension and rarely with hypertension. We present the case of a 53-year-old woman with hypertension and echocardiographic features of tamponade...
2.
Gutierrez F, Lopez L, Galera C, Tiraboschi J, Portu J, Garcia-Fraile L, et al.
Clin Infect Dis
. 2024 Jul;
80(2):371-380.
PMID: 38959300
Background: Non-AIDS defining malignancies present a growing challenge for persons with human immunodeficiency virus (HIV, PWH), yet tailored interventions for timely cancer diagnosis are lacking. The Spanish IMPAC-Neo protocol was...
3.
Valencia M, Pirogova T, Romera D, Montero M, Tasias M, Sanz J, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 May;
43(3):125-132.
PMID: 38735831
Introduction: Lung cancer (LC) screening detects tumors early. The prospective GESIDA 8815 study was designed to assess the usefulness of this strategy in HIV + people (PLHIV) by performing a...
4.
Hidalgo-Tenorio C, Sequera S, Vivancos M, Vinuesa D, Collado A, de Los Santos I, et al.
Int J Antimicrob Agents
. 2024 Apr;
63(6):107164.
PMID: 38574873
Objective: Multiple strategies have been utilised to reduce the incidence of HIV, including PrEP and rapid antiretroviral therapy initiation. The study objectives were to evaluate the efficacy, safety, satisfaction, treatment...
5.
Corma-Gomez A, Cabello A, Orviz E, Morante-Ruiz M, Ayerdi O, Al-Hayani A, et al.
J Med Virol
. 2024 Mar;
96(3):e29511.
PMID: 38469884
To date, former research about the impact of HIV infection on mpox poor outcomes is still limited and controversial. Therefore, the aim of this study was to assess the impact...
6.
Vinuela L, De Salazar A, Fuentes A, Serrano-Conde E, Falces-Romero I, Pinto A, et al.
J Med Virol
. 2023 Dec;
95(12):e29287.
PMID: 38084763
To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and integrase strand transfer inhibitors (INSTI) in Spain during...
7.
Sallabanda M, Vera J, Perez J, Matute R, Montero M, De Pablo A, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067283
(1) Background: Our purpose is to describe the design of a phase II clinical trial on 5-fraction proton therapy for chordomas and chondrosarcomas of the skull base and to present...
8.
Solana-Altabella A, Monte-Boquet E, Montero M, Perez-Huertas P, Cuellar-Monreal M, Salavert M, et al.
Medicine (Baltimore)
. 2023 Jan;
101(49):e32208.
PMID: 36626459
To evaluate the reasons for changing to monotherapy with protease inhibitors, together with the proportion and reasons for the interruption to treatment, in patients who have been treated at some...
9.
Del Amo J, Polo R, Moreno S, Martinez E, Cabello A, Iribarren J, et al.
AIDS
. 2022 Nov;
36(15):2171-2179.
PMID: 36382436
Background: Effective, safe, and affordable antivirals are needed for coronavirus disease 2019 (COVID-19). Several lines of research suggest that tenofovir may be effective against COVID-19, but no large-scale human studies...
10.
Troya J, Duenas C, Irazola I, de Los Santos I, De la Fuente S, Gil D, et al.
Medicine (Baltimore)
. 2022 Jun;
101(24):e29252.
PMID: 35713430
Switching dual therapy with dolutegravir (DTG) plus rilpivirine (RPV) was assessed in the SWORD-1 and SWORD-2 studies. Real-life data regarding the immunological impact of this approach on CD4+ and CD8+...